267. Exits: Greg Lucier - Billion Dollar Exits and Why He’s Still On the Hunt to Acquire MedTech Assets to Challenge Strategics
Description
00:00 Introduction to Greg Lucier and His Journey
03:00 Transition from GE to Medical Device Industry
05:49 Lessons Learned at GE
09:07 Embracing Risk and Learning from Failure
11:54 Cultural Adaptation at Invitrogen
14:58 The Evolution of Genomics in Medicine
18:06 Transforming Invitrogen to Life Technologies
21:12 Merging Companies and Creating New Cultures
24:09 Navigating the Financial Crisis and Growth Strategies
27:07 The Sale of Life Technologies
29:59 Taking the Helm at Nuvasive
32:48 Implementing Change and Growth at Nuvasive
43:35 Cultural Transformation and Leadership
46:03 Manufacturing and Globalization Strategies
48:58 Lessons from NuVasive's Growth
52:07 The Future of Spine Surgery
54:54 Navigating Business Ethics in Healthcare
57:05 The Role of People in Business Success
01:00:02 Transitioning to Private Equity and New Ventures
01:03:04 Challenges in the Healthcare Industry
01:07:00 The Future of Corsa Medical
01:09:57 Rapid Fire Questions and Personal Insights
Don’t Let Cybersecurity Risks Delay Your Medical Device Premarket Approval. Check out BlueGoatCyber.com
Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.
Subscribe to our newsletter: https://www.stateofmedtechpodcast.com/
Subscribe to our Youtube Channel
https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg
Follow The State of MedTech on:
Follow Omar M. Khateeb on
United States
